Upcoming Events
  1. ALTG open MAC and SAC meetings

    November 20
  2. Virtual 2020 World Conference on Lung Cancer Singapore

    January 28, 2021 @ 8:00 am - January 31, 2021 @ 5:00 pm

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

ALTG 14/002 NIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer progressing after first or second line chemotherapy – P Mitchell

NIVORAD is a trial to determine the activity and safety of combining nivolumab with local, palliative SABR to an extra-thoracic metastasis in patients with advanced NSCLC. The planned sample size is 120 at approximately 25 ANZ sites and lead HREC approval was received in December 2015. Participating sites are currently completing local governance requirements. The trial was opened to recruitment in January 2017.

State/TerritorySitePIActivation DateEstimated Recruitment
NSWChris O'Brien LifehouseSteven Kao10
Prince of Wales HospitalCraig Lewis8
Royal North Shore HospitalNick Pavlakis6 Jan 201710
Sydney Adventist HospitalCsilla Hasovits5
The Tweed HospitalEhtesham Abdi8
QLDGenesis Cancer CareKen O'Byrne6
Nambour General Hospital (Sunshine Coast Health Service District)Kathleen Houston6
Princess Alexandra HospitalKen O'Byrne20
Royal Brisbane and Women's HospitalBrett Hughes10
Townsville HospitalSuresh Varma6 Jan 201710
SAFlinders Medical CentreChris Karapetis15
Royal Adelaide HospitalHien Le10
TASRoyal Hobart HospitalLouise Nott6
VICAustin HospitalPaul Mitchell18
Peninsula South Eastern Haematology & Oncology GroupVinod Ganju6
St Vincent's HospitalSue-Anne McLachlan6
The Alfred HospitalMaggie Moore15
Western Health Sunshine/Western Health Lung Oncology (Footscray)Shankar Siva10
WASir Charles Gairdner HospitalArman Hasani4
Other (NZ)Auckland City Hospital - Auckland District Health BoardGeorge Laking6

Study Contacts

Study Chair: Paul Mitchell     paul.mitchell@austin.org.au

CTC Trial Coordinator: Annie Yeung     NIVORAD@ctc.usyd.edu.au